VPT — VentriPoint Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$30.65m
- CA$30.63m
- CA$0.05m
Annual cashflow statement for VentriPoint Diagnostics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.32 | -1.85 | -3.88 | -4.87 | -4.87 |
| Depreciation | |||||
| Non-Cash Items | 0.403 | 0.572 | 1.15 | 1.02 | 0.549 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.478 | 0.123 | -0.463 | -0.331 | 0.452 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.38 | -1.1 | -3.15 | -4.14 | -3.8 |
| Capital Expenditures | -0.017 | -0.004 | -0.004 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.017 | -0.004 | -0.004 | 0 | — |
| Financing Cash Flow Items | 0.043 | -0.067 | -0.751 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.34 | 1.62 | 11.9 | 0.088 | -0.102 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.053 | 0.512 | 8.74 | -4.08 | -3.89 |